Astellas Venture Management
South San Francisco, Californiaastellasventure.com
Overview
Astellas Venture Management (AVM) is the corporate venture capital arm of Astellas Pharma Inc., dedicated to supporting pre-clinical, cutting-edge science that can bring value to patients . AVM provides equity investments to private, early-stage companies developing therapeutic programs and platform technologies, helping them to advance their innovations faster . AVM is a strategic investor, making investments in science that will enhance the current Astellas R&D pipeline or that could catalyze new directions in discovery research .
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Sidewinder | Apr 2026 | Series B | Co-investor |
| Sidewinder Therapeutics | Apr 2026 | Series B | Co-investor |
| Pallando Therapeutics | Jun 2025 | Seed | Co-investor |
| Solu Therapeutics | Apr 2025 | Series A | Co-investor |
| Phoremost | Sep 2024 | Series B Extension | Co-investor |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.